InflaRx N.V.
IFRXNASDAQHEALTHCARE
About InflaRx N.V.
InflaRx NV, a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company is headquartered in Jena, Germany.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- USA
- Fiscal year end
- December
- Website
- inflarx.de
Quotes and fundamental data are delayed and provided for informational purposes only — nothing on this page is financial advice. Figures are as reported by the company and its data providers and may be revised. Estimates reflect analyst consensus at the time of each report.